LEXXVSSLXN• 12 Months (Normalized)
LEXX vs SLXN (Lexaria Bioscience Corp. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LEXX Performance $3.24
-77.37%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
SLXN Performance $0.32
-99.07%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin LEXX LEADS
+21.7 pts
LEXX outperforming by 21.70 percentage points
LEXXSLXN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LEXX SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(247 dates)
| Date | LEXX Price | LEXX Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $3.24 | -77.37% | $0.32 | -99.07% | +21.70% |
| Sep 22, 2026 | $- | $0.39 | -98.85% | - | |
| Sep 21, 2026 | $3.43 | -76.04% | $0.54 | -98.40% | +22.36% |
| Sep 18, 2026 | $3.24 | -77.33% | $0.44 | -98.72% | +21.39% |
| Sep 17, 2026 | $3.29 | -76.98% | $0.38 | -98.88% | +21.90% |
| Sep 16, 2026 | $3.10 | -78.35% | $0.34 | -99.00% | +20.65% |
| Sep 15, 2026 | $3.21 | -77.54% | $0.34 | -99.00% | +21.46% |
| Sep 14, 2026 | $3.55 | -75.17% | $0.39 | -98.87% | +23.70% |
| Sep 11, 2026 | $3.97 | -72.23% | $0.36 | -98.95% | +26.72% |
| Sep 10, 2026 | $4.05 | -71.67% | $0.42 | -98.76% | +27.09% |
| Sep 09, 2026 | $6.60 | -53.83% | $0.35 | -98.97% | +45.14% |
| Sep 08, 2026 | $9.37 | -34.45% | $0.35 | -98.99% | +64.54% |
| Sep 04, 2026 | $14.15 | -1.01% | $0.35 | -98.96% | +97.95% |
| Sep 03, 2026 | $12.32 | -13.82% | $0.35 | -98.96% | +85.14% |
| Sep 02, 2026 | $13.21 | -7.63% | $0.35 | -98.97% | +91.34% |
Page 1 of 17